The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

Drug-induced liver injury cases are increasing, with common medications and supplements posing hidden dangers, especially for ...